CLOs on the Move

Originally founded in 1992 as a niche site management organization, D. Anderson & Company emerged as a model for crafting clinical strategies based on investigative site needs. Today as DAC Patient Recruitment Services, an Imperial company, we`ve parlayed that experience into our current, site-focused business model.   Effective March 29, 2011, DAC was acquired by Imperial—a privately owned clinical research support organization with offices in Michigan, New Jersey and the United Kingdom. Since its origins in 1945, Imperial, has become one of the world`s premier support organizations for clinical trial sponsors and contract research organizations.   With unified standards, central management and streamlined client ...

Originally founded in 1992 as a niche site management organization, D. Anderson & Company emerged as a model for crafting clinical strategies based on investigative site needs. Today as DAC Patient Recruitment Services, an Imperial company, we`ve parlayed that experience into our current, site-focused business model.   Effective March 29, 2011, DAC was acquired by Imperial—a privately owned clinical research support organization with offices in Michigan, New Jersey and the United Kingdom. Since its origins in 1945, Imperial, has become one of the world`s premier support organizations for clinical trial sponsors and contract research organizations.   With unified standards, central management and streamlined client communication, the Imperial Family of Companies includes DAC Patient Recruitment Services, ClinicaLingua Translations Services and Imperial Graphics--three vertically integrated brands offering clients true service synergy.   Together, we`re taking patient recruitment for clinical trials to a higher level with unique strategies that yield rapid enrollment, risk reduction and return on investment. Our unique strategies have boosted enrollment by 100 percent and reduced attrition by 48 percent on average. We`ve successfully managed recruitment and retention programs representing 100,000 patients at 16,000 sites around the world.

More>>

<<Less